In CIS-resistant CAR cells, which are developed from CAR human oral cancer cells, RES has been observed to increase the protein levels of Bax and Bad and decrease the protein levels of Bcl-2 and the phosphorylation of Bad on serine 136 [63]. Here, BAD is linked to in situ carcinoma.